title: Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance.
abstract: Cardiac catheterization was undertaken in 87 patients (for a total of 89 studies) with ventricular septal defects, including 58 patients with moderate or severe elevation of pulmonary arteriolar resistance. When resting resistance was less than or equal to 7.9 U . m2, it always decreased with isoproterenol and no postoperative problems were experienced with pulmonary vascular obstructive disease. In 36 patients resting resistance measured greater than or equal to 8 U . m2. In 17 of these patients it decreased to less than 7 U . m2 with isoproterenol. Fifteen patients were operated on and postoperative problems with pulmonary vascular disease were experienced only in the single patient whose repair broke down. Surgery was undertaken in 4 of 19 patients in whom resistance did not decrease to less than 7 U . m2 with isoproterenol and advanced pulmonary vascular disease was evident in the 3 patients with follow-up observation. Correlation between measured resistance and other hemodynamic parameters was only fair. A pulmonary to systemic resistance ratio greater than or equal to 0.75 always indicated high absolute resistance but resistance ratios less than 0.75 were found quite frequently in the group with limited response to isoproterenol. These data argue that a reliable estimate of resistance, less than 7 U . m2, with a vasodilator predicts a good postoperative response regardless of measurements at rest or other hemodynamic parameters. Although observations on postoperative progress of patients with resistance greater than 7 U . m2 with a vasodilator are limited, a good postoperative course is unlikely unless resistance can be lowered to a level close to 7 U . m2.
authors.affiliation: Cardiology Department, Green Lane Hospital, Auckland, New Zealand.
authors.forename: J M
authors.initials: JM
authors.lastname: Neutze
authors.forename: T
authors.initials: T
authors.lastname: Ishikawa
authors.forename: P M
authors.initials: PM
authors.lastname: Clarkson
authors.forename: A L
authors.initials: AL
authors.lastname: Calder
authors.forename: B G
authors.initials: BG
authors.lastname: Barratt-Boyes
authors.forename: A R
authors.initials: AR
authors.lastname: Kerr
mesh_terms: D000328:Adult; D002648:Child; D005500:Follow-Up Studies; D006345:Heart Septal Defects, Ventricular / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D011652:Pulmonary Circulation / Q000187:drug effects; D012146:Rest; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D007545:Isoproterenol